The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
IgA nephropathy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Navarra, S. V., Guzmán, R. M., Gallacher, A. E., Hall, S., Levy, R. A., Jimenez, R. E., Li, E. K.-M., Thomas, M., Kim, H.-Y., León, M. G., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61354-2 · Cited by 2,074
A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Cattran, D. C., Coppo, R., Cook, H. T., Feehally, J., Roberts, I. S. D., Troyanov, S., Alpers, C. E., Amore, A., Barratt, J., et al. (2009) · Kidney International · doi:10.1038/ki.2009.243 · Cited by 1,235
Self-citationA Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Roberts, I. S. D., Cook, H. T., Troyanov, S., Alpers, C. E., Amore, A., Barratt, J., Berthoux, F., Bonsib, S., Bruijn, J. A., et al. (2009) · Kidney International · doi:10.1038/ki.2009.168 · Cited by 1,038
Self-citationde Zeeuw, D., Remuzzi, G., Parving, H.-H., Keane, W. F., Zhang, Z., Shahinfar, S., Snapinn, S., Cooper, M. E., Mitch, W. E., & Brenner, B. M. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00653.x · Cited by 975
The Pathophysiology of IgA Nephropathy
Suzuki, H., Kiryluk, K., Novak, J., Moldoveanu, Z., Herr, A. B., Renfrow, M. B., Wyatt, R. J., Scolari, F., Mestecky, J., Gharavi, A. G., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011050464 · Cited by 910
Self-citationIntensive supportive care plus immunosuppression in IgA nephropathy
Rauen, T., Eitner, F., Fitzner, C., Sommerer, C., Zeier, M., Otte, B., Panzer, U., Peters, H., Benck, U., Mertens, P. R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1415463 · Cited by 726
Remission of Proteinuria Improves Prognosis in IgA Nephropathy
Reich, H. N., Troyanov, S. A. A., Scholey, J. W., & Cattran, D. C. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007050526 · Cited by 639
Kiryluk, K., Li, Y., Scolari, F., Sanna-Cherchi, S., Choi, M., Verbitsky, M., Fasel, D., Lata, S., Prakash, S., Shapiro, S., et al. (2014) · Nature Genetics · doi:10.1038/ng.3118 · Cited by 628
Self-citationGenome-wide association study identifies susceptibility loci for IgA nephropathy
Gharavi, A. G., Kiryluk, K., Choi, M., Li, Y., Hou, P., Xie, J., Sanna-Cherchi, S., Men, C. J., Julian, B. A., Wyatt, R. J., et al. (2011) · Nature Genetics · doi:10.1038/ng.787 · Cited by 624
Self-citationTomana, M., Novak, J., Julian, B. A., Matousovic, K., Konecny, K., & Mestecky, J. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5535 · Cited by 498
Self-citationCoppo, R., on behalf of the VALIGA study of the ERA-EDTA Immunonephrology Working Group, Troyanov, S., Bellur, S., Cattran, D., Cook, H. T., Feehally, J., Roberts, I. S. D., Morando, L., Camilla, R., et al. (2014) · Kidney International · doi:10.1038/ki.2014.63 · Cited by 498
Ju, T., & Cummings, R. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.262438199 · Cited by 487
Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels
Moldoveanu, Z., Wyatt, R. J., Lee, J. Y., Tomana, M., Julian, B. A., Mestecky, J., Huang, W.-Q., Anreddy, S. R., Hall, S., Hastings, M. C., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002185 · Cited by 422
Self-citationRadhakrishnan, J., & Cattran, D. C. (2012) · Kidney International · doi:10.1038/ki.2012.280 · Cited by 417
A Controlled Trial of Fish Oil in IgA Nephropathy
Donadio, J. V., Bergstralh, E. J., Offord, K. P., Spencer, D. C., & Holley, K. E. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411033311804 · Cited by 408
Kiryluk, K., Li, Y., Sanna-Cherchi, S., Rohanizadegan, M., Suzuki, H., Eitner, F., Snyder, H. J., Choi, M., Hou, P., Scolari, F., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002765 · Cited by 383
Self-citationPredicting the Risk for Dialysis or Death in IgA Nephropathy
Berthoux, F., Mohey, H., Laurent, B., Mariat, C., Afiani, A., & Thibaudin, L. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010040355 · Cited by 361
Current Understanding of the Role of Complement in IgA Nephropathy
Maillard, N., Wyatt, R. J., Julian, B. A., Kiryluk, K., Gharavi, A., Fremeaux-Bacchi, V., & Novak, J. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014101000 · Cited by 338
Self-citationGalactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG
Tomana, M., Matoušovic, K., Julian, B. A., Radl, J., Konecný, K., & Mestecky, J. (1997) · Kidney International · doi:10.1038/ki.1997.361 · Cited by 318
Controlled Prospective Trial of Prednisolone and Cytotoxics in Progressive IgA Nephropathy
Ballardie, F. W., & Roberts, I. S. D. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v131142 · Cited by 317
Yu, X.-Q., Li, M., Zhang, H., Low, H.-Q., Wei, X., Wang, J.-Q., Sun, L.-D., Sim, K.-S., Li, Y., Foo, J.-N., et al. (2012) · Nature Genetics · doi:10.1038/ng.1047 · Cited by 312
Podocytopenia and disease severity in IgA nephropathy
Lemley, K. V., Lafayette, R. A., Safai, M., Derby, G., Blouch, K., Squarer, A., & Myers, B. D. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00269.x · Cited by 296
Moura, I. C., Centelles, M. N., Arcos-Fajardo, M., Malheiros, D. M., Collawn, J. F., Cooper, M. D., & Monteiro, R. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.4.417 · Cited by 293
Aberrant IgA1 Glycosylation Is Inherited in Familial and Sporadic IgA Nephropathy
Gharavi, A. G., Moldoveanu, Z., Wyatt, R. J., Barker, C. V., Woodford, S. Y., Lifton, R. P., Mestecky, J., Novak, J., & Julian, B. A. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007091052 · Cited by 284
Self-citationGalactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy
ALLEN, A. C., HARPER, S. J., & FEEHALLY, J. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb03724.x · Cited by 277
IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1
Suzuki, H., Moldoveanu, Z., Hall, S., Brown, R., Vu, H. L., Novak, L., Julian, B. A., Tomana, M., Wyatt, R. J., Edberg, J. C., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33189 · Cited by 277
Self-citationAutoantibodies Targeting Galactose-Deficient IgA1 Associate with Progression of IgA Nephropathy
Berthoux, F., Suzuki, H., Thibaudin, L., Yanagawa, H., Maillard, N., Mariat, C., Tomino, Y., Julian, B. A., & Novak, J. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012010053 · Cited by 272
Self-citationMaes, B. D., Oyen, R., Claes, K., Evenepoel, P., Kuypers, D., Vanwalleghem, J., Damme, B. V., & Vanrenterghem, Y. F. C. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00588.x · Cited by 269
Kiryluk, K., Moldoveanu, Z., Sanders, J. T., Eison, T. M., Suzuki, H., Julian, B. A., Novak, J., Gharavi, A. G., & Wyatt, R. J. (2011) · Kidney International · doi:10.1038/ki.2011.16 · Cited by 266
Self-citationRoberts, I. S. D. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.92 · Cited by 263
Prognosis in IgA Nephropathy: 30-Year Analysis of 1,012 Patients at a Single Center in Japan
Moriyama, T., Tanaka, K., Iwasaki, C., Oshima, Y., Ochi, A., Kataoka, H., Itabashi, M., Takei, T., Uchida, K., & Nitta, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091756 · Cited by 259
Launay, P., Grossetête, B., Arcos-Fajardo, M., Gaudin, E., Torres, S. P., Beaudoin, L., Patey-Mariaud de Serre, N., Lehuen, A., & Monteiro, R. C. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.11.1999 · Cited by 254
Ibels, L. S., & Györy, A. Z. (1994) · Medicine · doi:10.1097/00005792-199403000-00002 · Cited by 244
Frisch, G., Lin, J., Rosenstock, J., Markowitz, G., D'Agati, V., Radhakrishnan, J., Preddie, D., Crew, J., Valeri, A., & Appel, G. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh974 · Cited by 244
Novak, J., Tomana, M., Brown, R., Hall, S., Novak, L., Julian, B. A., Wyatt, R. J., Mestecky, J., & Matousovic, K. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.67107.x · Cited by 228
Self-citationThe genetics and immunobiology of IgA nephropathy
Kiryluk, K., & Novak, J. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74475 · Cited by 224
Self-citationPathogenesis of IgA nephropathy
Lai, K. N. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.58 · Cited by 221
Self-citationCorticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study
Tesar, V., Troyanov, S., Bellur, S., Verhave, J. C., Cook, H. T., Feehally, J., Roberts, I. S. D., Cattran, D., & Coppo, R. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014070697 · Cited by 217
Szeto, C.-C., Lai, F. M.-M., To, K.-F., Yuk-Hwa Wong, T., Chow, K.-M., Cheung-Lung Choi, P., Lui, S.-F., & Kam-Tao Li, P. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00659-3 · Cited by 212
Abnormal miR-148b Expression Promotes Aberrant Glycosylation of IgA1 in IgA Nephropathy
Serino, G., Sallustio, F., Cox, S. N., Pesce, F., & Schena, F. P. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011060567 · Cited by 206
Self-citationMycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy
Tang, S., Leung, J. C. K., Chan, L. Y. Y., Lui, Y. H., Tang, C. S. O., Kan, C. H., Ho, Y. W., & Lai, K. N. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00460.x · Cited by 198
Self-citationLong-term study of mycophenolate mofetil treatment in IgA nephropathy
Tang, S. C. W., Tang, A. W. C., Wong, S. S. H., Leung, J. C. K., Ho, Y. W., & Lai, K. N. (2010) · Kidney International · doi:10.1038/ki.2009.499 · Cited by 192
Self-citationCorticosteroid therapy in IgA nephropathy
Lv, J., Xu, D., Perkovic, V., Ma, X., Johnson, D. W., Woodward, M., Levin, A., Zhang, H., & Wang, H. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011111112 · Cited by 190
Long-Term Outcomes of IgA Nephropathy Presenting with Minimal or No Proteinuria
Gutiérrez, E., Zamora, I., Ballarín, J. A., Arce, Y., Jiménez, S., Quereda, C., Olea, T., Martínez-Ara, J., Segarra, A., Bernis, C., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012010063 · Cited by 185
Moura, I. C., Arcos-Fajardo, M., Sadaka, C., Leroy, V., Benhamou, M., Novak, J., Vrtovsnik, F. C., Haddad, E., Chintalacharuvu, K. R., & Monteiro, R. C. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000115401.07980.0c · Cited by 182
Self-citationTransglutaminase is essential for IgA nephropathy development acting through IgA receptors
Berthelot, L., Papista, C., Maciel, T. T., Biarnes-Pelicot, M., Tissandie, E., Wang, P. H. M., Tamouza, H., Jamin, A., Bex-Coudrat, J., Gestin, A., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112005 · Cited by 182
Kawamura, T., Yoshimura, M., Miyazaki, Y., Okamoto, H., Kimura, K., Hirano, K., Matsushima, M., Utsunomiya, Y., Ogura, M., Yokoo, T., et al. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu020 · Cited by 180
Self-citationRuggenenti, P., Perna, A., Gherardi, G., Benini, R., & Remuzzi, G. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70054-0 · Cited by 176
Cytokines Alter IgA1 O-Glycosylation by Dysregulating C1GalT1 and ST6GalNAc-II Enzymes
Suzuki, H., Raska, M., Yamada, K., Moldoveanu, Z., Julian, B. A., Wyatt, R. J., Tomino, Y., Gharavi, A. G., & Novak, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.512277 · Cited by 170
Self-citationPodocyte injury induced by mesangial-derived cytokines in IgA nephropathy
Lai, K. N., Leung, J. C. K., Chan, L. Y. Y., Saleem, M. A., Mathieson, P. W., Tam, K. Y., Xiao, J., Lai, F. M., & Tang, S. C. W. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn441 · Cited by 170
Self-citationImplementation of proteomic biomarkers: making it work
Mischak, H., Ioannidis, J. P. A., Argiles, A., Attwood, T. K., Bongcam‐Rudloff, E., Broenstrup, M., Charonis, A., Chrousos, G. P., Delles, C., Dominiczak, A., et al. (2012) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2012.02674.x · Cited by 169
Self-citationShi, Y., Chen, W., Jalal, D., Li, Z., Chen, W., Mao, H., Yang, Q., Johnson, R. J., & Yu, X. (2012) · Kidney and Blood Pressure Research · doi:10.1159/000331453 · Cited by 166
Barbour, S. J., Cattran, D. C., Kim, S. J., Levin, A., Wald, R., Hladunewich, M. A., & Reich, H. N. (2013) · Kidney International · doi:10.1038/ki.2013.210 · Cited by 164
A Randomized Trial of High-Dose Compared with Low-Dose Omega-3 Fatty Acids in Severe IgA Nephropathy
DONADIO, J. V., LARSON, T. S., BERGSTRALH, E. J., & GRANDE, J. P. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v124791 · Cited by 160
Chronic kidney disease perspectives in Japan and the importance of urinalysis screening
Yamagata, K., Iseki, K., Nitta, K., Imai, H., Iino, Y., Matsuo, S., Makino, H., & Hishida, A. (2008) · Clinical and Experimental Nephrology · doi:10.1007/s10157-007-0010-9 · Cited by 156
The impact of sex in primary glomerulonephritis
Cattran, D. C., Reich, H. N., Beanlands, H. J., Miller, J., Scholey, J. W., Troyanov, S., & for the Genes, G. A. G. G. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm919 · Cited by 145
Addition of Azathioprine to Corticosteroids Does Not Benefit Patients with IgA Nephropathy
Pozzi, C., Andrulli, S., Pani, A., Scaini, P., Vecchio, L. D., Fogazzi, G., Vogt, B., Cristofaro, V. D., Allegri, L., Cirami, L. C., et al. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010010117 · Cited by 143
Smerud, H. K., Barany, P. F., Lindstrom, K., Fernström, A., Sandell, A., Påhlsson, P., & Fellström, B. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr052 · Cited by 139
IgA Nephropathy: Molecular Mechanisms of the Disease
Mestecky, J. F., Raška, M., Julian, B. A., Gharavi, A. G., Renfrow, M. B., Moldoveanu, Z., Novak, L., Matoušovic, K., & Novák, J. (2012) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130216 · Cited by 137
Lai, K. N., Leung, J. C. K., Chan, L. Y. Y., Saleem, M. A., Mathieson, P. W., Lai, F. M., & Tang, S. C. W. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00423.2007 · Cited by 136
Self-citationPathogenesis of Immunoglobulin A Nephropathy: Recent Insight from Genetic Studies
Kiryluk, K., Novák, J., & Gharavi, A. G. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-041811-142014 · Cited by 130
Identification of new susceptibility loci for IgA nephropathy in Han Chinese
Li, M., Foo, J. N., Wang, J. Q., Low, H.-Q., Tang, X.-Q., Toh, K. Y., Yin, P.-R., Khor, C. C., Goh, Y.-F., Irwan, I. D., et al. (2015) · Nature Communications · doi:10.1038/ncomms8270 · Cited by 130
Nishiyama, A., Konishi, Y., Ohashi, N., Morikawa, T., Urushihara, M., Maeda, I., Hamada, M., Kishida, M., Hitomi, H., Shirahashi, N., et al. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq371 · Cited by 126
Berthelot, L., Robert, T., Vuiblet, V., Tabary, T., Braconnier, A., Dramé, M., Toupance, O., Rieu, P., Monteiro, R. C., & Touré, F. (2015) · Kidney International · doi:10.1038/ki.2015.158 · Cited by 124
Hogg, R. J., Lee, J. Y., Nardelli, N., Julian, B. A., Cattran, D., Waldo, B., Wyatt, R. J., Jennette, J. C., Sibley, R. K., Hyland, Κ., et al. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01020905 · Cited by 124
Hogg, R. J., Bay, R. C., Jennette, J. C., Sibley, R. K., Kumar, S., Fervenza, F. C., Appel, G. B., Cattran, D., Fischer, D., Hurley, R. M., et al. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.06.013 · Cited by 119
Pattern of biopsy-proven renal disease in a single center of south India: 19 years experience
Das, U., Dakshinamurty, K., & Prayaga, A. K. (2011) · Indian Journal of Nephrology · doi:10.4103/0971-4065.85482 · Cited by 119
Prediction of Outcomes in Crescentic IgA Nephropathy in a Multicenter Cohort Study
Lv, J., Yang, Y., Zhang, H., Chen, W., Pan, X., Guo, Z., Wang, C., Li, S., Zhang, J., Zhang, J., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012101017 · Cited by 118
Desmopressin Acetate in Percutaneous Ultrasound-Guided Kidney Biopsy: A Randomized Controlled Trial
Manno, C., Bonifati, C., Torres, D. D., Campobasso, N., & Schena, F. P. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.12.019 · Cited by 117
Self-citationYokoyama, H., Sugiyama, H., Satō, H., Taguchi, T., Nagata, M., Matsuo, S., Makino, H., Watanabe, T., Saito, T., Kiyohara, Y., et al. (2012) · Clinical and Experimental Nephrology · doi:10.1007/s10157-012-0673-8 · Cited by 108
Wyatt, R. J., Julian, B. A., Baehler, R. W., Stafford, C. C., McMorrow, R. G., Ferguson, T., Jackson, E., Woodford, S. Y., Miller, P. M., & Kritchevsky, S. B. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v95853 · Cited by 105
External suppression causes the low expression of the Cosmc gene in IgA nephropathy
Qin, W., Zhong, X., Fan, J. M., Zhang, Y. J., Liu, X. R., & Ma, X. Y. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm781 · Cited by 103
Kidney Disease Screening Program in Japan
Imai, E., Yamagata, K., Iseki, K., Iso, H., Horio, M., Mkino, H., Hishida, A., & Matsuo, S. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00980207 · Cited by 103
Lv, J., Zhang, H., Zhou, Y., Li, G., Zou, W.-Z., & Wang, H. (2008) · Nephrology · doi:10.1111/j.1440-1797.2007.00898.x · Cited by 100
Vuong, M. T., Hahn‐Zoric, M., Lundberg, S. G. G., Gunnarsson, I., van Kooten, C., Wramner, L., Seddighzadeh, M., Fernström, A., Hanson, L. Å., Lieu, T. D., et al. (2010) · Kidney International · doi:10.1038/ki.2010.314 · Cited by 97
Leung, J. C. K., Tsang, A. W. L., CHAN, D. T. M., & Lai, K. N. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v112241 · Cited by 95
Self-citationSerino, G., Pesce, F., Sallustio, F., Palma, G. D., Cox, S. N., Curci, C., Zaza, G., Lai, K. N., Leung, J. C. K., Tang, S. C. W., et al. (2015) · Kidney International · doi:10.1038/ki.2015.333 · Cited by 90
Self-citationAsao, R., Asanuma, K., Kodama, F., Akiba-Takagi, M., Hosoe-Nagai, Y., Seki, T., Takeda, Y., Ohsawa, I., Mano, S., Matsuoka, K., et al. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08110811 · Cited by 89
Self-citationIgA nephropathy: prognostic classification of end-stage renal failure
Firmat, L., Briançon, S., Hestin, D., Aymard, B., Renoult, E., Huu, T. C., Kessler, M., & de l'Est, L. D. N. (1997) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/12.12.2569 · Cited by 88
Kim, M. J., McDaid, J., McAdoo, S. P., Barratt, J., Molyneux, K., Masuda, E. S., Pusey, C. D., & Tam, F. W. K. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102603 · Cited by 80
Szeto, C.-C., & Li, P. K.-T. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.50 · Cited by 80
Ferraro, P. M., Ferraccioli, G., Gambaro, G., et al. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn454 · Cited by 79
Role of let-7b in the regulation ofN-acetylgalactosaminyltransferase 2 in IgA nephropathy
Serino, G., Sallustio, F., Curci, C., Cox, S. N., Pesce, F., Palma, G. D., & Schena, F. P. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv032 · Cited by 77
Self-citationNieuwhof, C. M. G., Kruytzer, M., Frederiks, P., & Vriesman, P. J. C. V. B. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v31.pm9631840 · Cited by 76
ACEI/ARB therapy for IgA nephropathy: a meta analysis of randomised controlled trials
Cheng, J., Zhang, W., Zhang, X. H., He, Q., Tao, X. J., & Jh, C. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02038.x · Cited by 75
The Endoplasmic Reticulum Chaperone Cosmc Directly Promotes in Vitro Folding of T-synthase
Aryal, R. P., Ju, T., & Cummings, R. D. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.065169 · Cited by 75
Kataoka, H., Ohara, M., Shibui, K., Sato, M., Suzuki, T., Amemiya, N., Watanabe, Y., Honda, K., Mochizuki, T., & Nitta, K. (2012) · Clinical and Experimental Nephrology · doi:10.1007/s10157-012-0613-7 · Cited by 73
n-3 Fatty Acids and Renal Diseases
Caterina, R. D., Endres, S., Kristensen, S. D., & Schmidt, E. B. (1994) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80896-1 · Cited by 72
Angiotensin II Receptor Type 1 Gene Expression in Human Glomerulonephritis and Diabetes Mellitus
Wagner, J., Gehlen, F., Ciechanowicz, A., & Ritz, E. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v103545 · Cited by 69
Biomarkers in IgA nephropathy: relationship to pathogenetic hits
Hastings, M. C., Moldoveanu, Z., Suzuki, H., Berthoux, F. C., Julian, B. A., Sanders, J. T., Renfrow, M. B., Novák, J., & Wyatt, R. J. (2013) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2013.856878 · Cited by 69
IgA induced activation of human mesangial cells: Independent of FcαR1 (CD 89)
Diven, S. C., Caflisch, C. R., Hammond, D. K., Weigel, P. H., Oka, J. A., & Goldblum, R. M. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00054.x · Cited by 60
Haghpanah, V., Fallah, P., Tavakoli, R., Naderi, M., Samimi, H., Soleimani, M., & Larijani, B. A. (2015) · Tumor Biology · doi:10.1007/s13277-015-3923-z · Cited by 54
The incidence of biopsy-proven IgA nephropathy is associated with multiple socioeconomic deprivation
McQuarrie, E. P., Mackinnon, B., McNeice, V., Fox, J. G., & Geddes, C. (2013) · Kidney International · doi:10.1038/ki.2013.329 · Cited by 53
Long-term prognosis of clinically early IgA nephropathy is not always favorable
Lee, H., Hwang, J. H., Paik, J. H., Ryu, H. J., Kim, D. K., Chin, H. J., Oh, Y. K., Joo, K. W., Lim, C. S., Kim, Y. S., et al. (2014) · BMC Nephrology · doi:10.1186/1471-2369-15-94 · Cited by 48
Aliskiren combined with losartan in immunoglobulin A nephropathy: an open-labeled pilot study
Tang, S. C. W., Lin, M. Y., Tam, S., Au, W., Ma, M. K. M., Yap, D. Y. H., Ho, Y. W., & Lai, K. N. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr349 · Cited by 39
Self-citationKnoop, T., Vågane, A. M., Vikse, B. E., Svarstad, E., Magnúsdóttir, B. T., Leh, S. M., Reisæter, A. V., & Bjørneklett, R. O. (2015) · American Journal of Nephrology · doi:10.1159/000381403 · Cited by 34
Stratta, P., Canavese, C., Ciccone, G., Barolo, S., Dall’Omo, A. M., Fasano, M. E., Mazzola, G. A., Berutti, S., Fop, F., Curtoni, E. S., et al. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70144-7 · Cited by 31
Development of animal models of human IgA nephropathy
Suzuki, H., Suzuki, Y., Novák, J., & Tomino, Y. (2014) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2014.07.002 · Cited by 30
Self-citationSzeto, C., Kwan, B. C., Chow, K., Leung, C., & Li, P. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062736 · Cited by 23
Polymorphism of DEFA in Chinese Han population with IgA nephropathy
Xu, R., Feng, S., Li, Z., Fu, Y., Yin, P., Ai, Z., Liu, W., Yu, X., & Li, M. (2014) · Human Genetics · doi:10.1007/s00439-014-1464-y · Cited by 19
Liu, R., Hu, B., Li, Q., Jing, X., Zhong, C., Chang, Y., Liao, Q., Lam, M. F., Leung, J. C. K., Lai, K. N., et al. (2015) · Gene · doi:10.1016/j.gene.2015.06.041 · Cited by 15
Self-citationShen, P., Ding, X., Ten, J., Ji, J., Zou, J., & Fang, Y. (2006) · Nephron Clinical Practice · doi:10.1159/000092912 · Cited by 12
Cited by
Glycosylation in health and disease
Reily, C., Stewart, T. J., Renfrow, M. B., & Novak, J. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0129-4 · Cited by 2,075
The renaissance of complement therapeutics
Ricklin, D., Mastellos, D. C., Reis, E. S., & Lambris, J. D. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.156 · Cited by 379
Lafayette, R., Kristensen, J., Stone, A., Floege, J., Tesař, V., Trimarchi, H., Zhang, H., Eren, N., Paliege, A., Reich, H. N., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01554-4 · Cited by 337
Lafayette, R. A., Canetta, P. A., Rovin, B. H., Appel, G. B., Novak, J., Nath, K. A., Sethi, S., Tumlin, J. A., Mehta, K., Hogan, M., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016060640 · Cited by 300
Self-citationA Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy
Mathur, M., Barratt, J., Chacko, B., Chan, T. M., Kooienga, L., Oh, K.-H., Sahay, M., Suzuki, Y., Wong, M. G., Yarbrough, J., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2305635 · Cited by 239
Metadata
- Authors
- Lai, K. N., Tang, S. C. W., Schena, F. P., Novak, J., Tomino, Y., Fogo, A. B., & Glassock, R. J.
- Venue
- Nature Reviews Disease Primers
- Published
- 2016-02-11
- Volume
- 2
- Issue
- 1
- Pages
- 16001-16001
- ISSN
- 2056-676X (ISSN-L)
- OpenAlex
- W4211190065
- Cited by
- 508
- References
- 102
- FWCI
- 2.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.